If you\u2019re asking, \u201cHow do I know if my CBD is real?\u201d, it\u2019s probably because you\u2019ve already had your doubts. A product that has a strange effect. A label that claims 25% CBD but for which you\u2019ve never seen the certificate of analysis. A price that\u2019s too low to be true. This doubt is legitimate\u2014and there\u2019s a factual answer to it. Don99, our Master Hashmaker and 2nd-place winner at the 2026 CannaSwiss Cup, has been working in this industry for years. What he sees from the inside deserves to be stated clearly. <\/p>\n\n
CBD became legal faster than the regulations could keep up. In Switzerland, the Federal Narcotics Act (LStup) sets the THC threshold at a maximum of 1%<\/strong> for legal products. In France and the EU, the limit<\/strong> is 0.3%.<\/strong> Two markets, two thresholds, and a porous border between them. <\/p>\n\n In Switzerland, the Federal Office of Public Health (FOPH) regulates CBD under the framework for cannabis-based products without psychoactive properties. The Federal Act on New Psychoactive Substances (LNPS), which took effect in 2024, adds an additional layer: it explicitly regulates new molecules such as HHC and H4CBD, which France banned via a decree as early as December 2021 but without a monitoring system as systematic as Switzerland\u2019s. <\/p>\n\n What this means in practice:<\/p>\n\n That’s where the structural problem begins.<\/p>\n\n A CBD resin labeled “20% CBD”: this is the concentration stated by the manufacturer or supplier. The figure is often based on an analysis of the raw material or an initial batch\u2014not necessarily the product you have in your hands. <\/p>\n\n Reasons why the actual rate differs from the advertised rate:<\/p>\n\n How to spot a potential discrepancy: ask for the COA. If the seller doesn\u2019t have one, if the lab listed is unknown, or if the document is several years old\u2014that\u2019s a red flag. The complete guide to reading a CBD lab report<\/a> explains every line of the document and what it really means. <\/p>\n\n This is the most serious problem in today’s market, and the one that consumers understand the least.<\/p>\n\n HHC (hexahydrocannabinol), H4CBD, and THCP: these molecules exist. They are psychoactive to varying degrees. And they can be found in products sold as \u201clegal CBD\u201d\u2014sometimes intentionally to produce an effect, sometimes due to cross-contamination in poorly regulated production chains. <\/p>\n\n This isn’t a conspiracy theory. It’s been documented. Fake CBD products containing synthetic cannabinoids have been the subject of warnings in France (ANSM) and Switzerland (OFSP) since 2022. A comprehensive article on counterfeit CBD products containing synthetic cannabinoids<\/a> details the mechanisms involved and the cases that have been identified. <\/p>\n\n What you need to know about these compounds: A standard COA doesn\u2019t always detect them. Chromatographic analysis (HPLC or GC-MS) that measures CBD only detects what it\u2019s looking for. If the lab isn\u2019t testing for HHC, it won\u2019t find it. That\u2019s why the quality of the COA\u2014what exactly it analyzes\u2014is just as important as its existence. <\/p>\n\n Three practical warning signs:<\/p>\n\n Where does the plant come from? What variety is it? What is its country of origin? What extraction method was used? This information exists in theory\u2014it is necessary to produce an accurate COA. In practice, however, it is rarely available to the end consumer. <\/p>\n\n The supply chain is often long: grower \u2192 extractor \u2192 wholesaler \u2192 importer \u2192 store. At each link in the chain, information can be lost or diluted. A wholesaler sells batches of resin with a generic \u201cSwitzerland\u201d origin, without any details on the strain or extraction method. <\/p>\n\n The problem isn’t that market participants are acting in bad faith. It’s structural: no one is required to share this information, and few have an incentive to do so\u2014because transparency imposes constraints. <\/p>\n\n The fact that the production of CBD resin involves different constraints than that of THC resin<\/a> explains why traceability begins with the plant itself: working with CBD strains containing less than 1% THC requires precise strain selection, which not every supplier can certify without documentation.<\/p>\n\n A COA (Certificate of Analysis) is an analysis report issued by an independent laboratory based on a product sample. It is the only document that links a manufacturer\u2019s claims to what a laboratory has actually measured. <\/p>\n\n Four key points to check first:<\/p>\n\n 1. The laboratory\u2019s identity<\/strong> \u2014 The lab\u2019s name must be verifiable. Look it up. Eurofins, Chemoverde, Arge Canna: these are well-known names. A \u201cLaboratory XYZ\u201d with no identifiable address or accreditation = a COA that cannot be verified. <\/p>\n\n 2. The lot number<\/strong> \u2014 The COA must include a lot number that matches the product you received. Ask your seller to verify that your product’s lot number matches the one on the COA. <\/p>\n\n 3. The panel analyzed<\/strong> \u2014 A minimal COA tests for CBD, THC, THCA, CBN, and CBG. A comprehensive COA includes an expanded panel of cannabinoids (HHC, H4CBD, etc.) and often solvent residues if chemical extraction was used. <\/p>\n\n 4. The date<\/strong> \u2014 A COA dated more than 18 months ago for a fast-moving consumer good raises questions. Deterioration is a real concern. <\/p>\n\n To learn more about how to read a COA in full: the article \u201cHow to Read a CBD Lab Report\u201d<\/a> covers each field, common pitfalls, and questions to ask your seller.<\/p>\n\n For a complete checklist of available practical tests, the article \u201cHow to Recognize Processed or Enriched CBD Hash\u201d<\/a> goes into much greater detail on each criterion.<\/p>\n\n These are synthetic or semi-synthetic cannabinoids. They exist, they\u2019re out there, and they raise a specific question: How can you tell if your CBD contains them? <\/p>\n\n HHC (hexahydrocannabinol)<\/strong> \u2014 Obtained by hydrogenating THC or CBD. Produces psychoactive effects comparable to those of THC, with varying intensity depending on the isomers (8R-HHC vs. 8S-HHC). Banned in France since the decree of December 30, 2021 (classified as a narcotic). In Switzerland, regulated by the LNPS\u2014its legal status depends on the concentration and the context in which it is marketed. <\/p>\n\n H4CBD (tetrahydrocannabidiol)<\/strong> \u2014 Obtained by hydrogenating CBD. Moderate psychoactive effects. Problem: It may be sold as \u201cenhanced CBD\u201d or \u201cfull-spectrum CBD\u201d by unscrupulous sellers. Banned in France since 2022. <\/p>\n\n THCP (tetrahydrocannabiphorol)<\/strong> \u2014 A THC analog that occurs naturally in cannabis in very low doses but is produced synthetically in higher concentrations. According to preliminary studies, it has up to 33 times greater affinity for the CB1 receptor than THC. Regulations vary by country. <\/p>\n\n Key takeaway: None of these compounds is CBD. Selling a product containing HHC and marketing it as \u201clegal CBD\u201d constitutes false advertising, regardless of the compound\u2019s legal status in your country. <\/p>\n\n For a comprehensive comparison of the effects, legality, and risks of each compound, the article \u201cHHC vs. CBD: Differences\u201d<\/a> provides a thorough overview of the topic with a detailed comparison chart.<\/p>\n\n The Swiss regulatory framework is often perceived as more permissive regarding CBD (higher THC threshold). In reality, it is more proactive regarding new substances: the LNPS allows for action to be taken on an emerging molecule without waiting for parliamentary approval, unlike the French system. This is why substances like HHC were able to circulate unregulated for longer in France than in Switzerland. <\/p>\n\n For consumers in France who order from Switzerland: A Swiss CBD product must comply with French regulations (THC < 0.3%) to be legal upon receipt in France. The Swiss 1% threshold applies only in Switzerland. For cross-border shipments, the destination country\u2019s regulations take precedence. <\/p>\n\n The article \u201cLegal CBD in Switzerland vs. France: What\u2019s Actually Changing\u201d<\/a> details the sticking points of cross-border trade and what the 2026 regulations are changing in both countries.<\/p>\n\n This isn’t a catalog. It’s a checklist of what a high-quality CBD hash should have\u2014whether you buy it from us or somewhere else. <\/p>\n\n Non-negotiable criteria:<\/strong><\/p>\n\n What you’ll find at Hash Gang:<\/strong> This isn’t just a marketing ploy. It’s the bare minimum required to have an honest conversation with the people who buy our products. <\/p>\n\n\n
\n\nThe 3 Structural Problems of the Market<\/h2>\n\n
Problem 1 \u2014 The actual rate is not always the advertised rate<\/h3>\n\n
\n
Problem 2 \u2014 Synthetic cannabinoids are hidden in CBD products<\/h3>\n\n
\n
Problem 3 \u2014 Traceability remains unclear across much of the market<\/h3>\n\n
\n\nHow to Read a COA: What the Document Really Tells You<\/h2>\n\n
\n\nThe 7 Signs of Processed or Enriched CBD Hash<\/h2>\n\n
\n
\n\nHHC, H4CBD, THCP: New Substances to Watch Out For<\/h2>\n\n
\n\nWhat the Law Says: Switzerland vs. France<\/h2>\n\n
Parameter<\/th> Switzerland<\/th> France<\/th><\/tr><\/thead> Legal THC Threshold<\/td> 1% (LStup)<\/td> 0.3% (as of 2021)<\/td><\/tr> Legal CBD<\/td> \u2705 Yes<\/td> \u2705 Yes (< 0.3% THC)<\/td><\/tr> HHC<\/td> \u26a0\ufe0f LNPS Box<\/td> \u274c Prohibited (Decree of December 30, 2021)<\/td><\/tr> H4CBD<\/td> \u26a0\ufe0f LNPS Box<\/td> \u274c Prohibited<\/td><\/tr> THCP<\/td> \u26a0\ufe0f LNPS Box<\/td> \u274c Prohibited<\/td><\/tr> COA Requirement<\/td> \u274c No (recommended)<\/td> \u274c No (recommended)<\/td><\/tr> Cross-border imports<\/td> \u26a0\ufe0f Authorized CH\u2192CH, export restrictions to FR<\/td> \u26a0\ufe0f Authorized under the terms of the LStup<\/td><\/tr><\/tbody><\/table><\/figure>\n\n
\n\nOur Selection: What a High-Quality CBD Hash Should Have<\/h2>\n\n
\n